This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978 May 15;21(5):578-87.

doi: 10.1002/ijc.2910210507.

Analysis of serum blocking factors against leukocyte dependent antibody in melanoma patients

E Murray, S Ruygrok, G W Milton, P Hersey

PMID: 350780
DOI: 10.1002/ijc.2910210507

Analysis of serum blocking factors against leukocyte dependent antibody in melanoma patients

E Murray et al. Int J Cancer. 1978.

. 1978 May 15;21(5):578-87.

doi: 10.1002/ijc.2910210507.

Authors

E Murray, S Ruygrok, G W Milton, P Hersey

PMID: 350780
DOI: 10.1002/ijc.2910210507

No abstract available

PubMed Disclaimer

Similar articles

Detection of a low-molecular-weight antigen on melanoma cells by a human antiserum in leukocyte-dependent antibody assays.
Hersey P, Murray E, Werkmeister J, McCarthy WH. Hersey P, et al. Br J Cancer. 1979 Oct;40(4):615-27. doi: 10.1038/bjc.1979.227. Br J Cancer. 1979. PMID: 91379 Free PMC article.
Human leukemia antigen. II. Purification.
Billing R, Terasaki PI. Billing R, et al. J Natl Cancer Inst. 1974 Dec;53(6):1639-43. J Natl Cancer Inst. 1974. PMID: 4530877 No abstract available.
Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients.
Murray E, McCarthy WH, Hersey P. Murray E, et al. Br J Cancer. 1977 Jul;36(1):7-14. doi: 10.1038/bjc.1977.148. Br J Cancer. 1977. PMID: 19029 Free PMC article.
Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma.
Halliday WJ, Maluish AE, Little JH, Davis NC. Halliday WJ, et al. Int J Cancer. 1975 Oct 15;16(4):645-58. doi: 10.1002/ijc.2910160415. Int J Cancer. 1975. PMID: 51836
Characterization of antigenic components of immune complexes isolated from a melanoma patient.
Cheng WC, Gupta RK, Morton DL. Cheng WC, et al. Immunol Invest. 1985 Aug;14(4):367-78. doi: 10.3109/08820138509022672. Immunol Invest. 1985. PMID: 4065936

See all similar articles

Cited by

Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients.
Hersey P, Edwards A, D'Alessandro G, MacDonald M. Hersey P, et al. Cancer Immunol Immunother. 1986;22(3):221-31. doi: 10.1007/BF00200037. Cancer Immunol Immunother. 1986. PMID: 3460702 Free PMC article.
Circulating immune complexes in carcinoma of uterine cervix.
Seth P, Balachandran N, Malaviya AN, Kumar R. Seth P, et al. Clin Exp Immunol. 1979 Oct;38(1):77-82. Clin Exp Immunol. 1979. PMID: 527257 Free PMC article.
Detection of a low-molecular-weight antigen on melanoma cells by a human antiserum in leukocyte-dependent antibody assays.
Hersey P, Murray E, Werkmeister J, McCarthy WH. Hersey P, et al. Br J Cancer. 1979 Oct;40(4):615-27. doi: 10.1038/bjc.1979.227. Br J Cancer. 1979. PMID: 91379 Free PMC article.
Characterization of an inhibitor of cell division released in tumour cell cultures.
Werkmeister J, Zaunders J, McCarthy W, Hersey P. Werkmeister J, et al. Clin Exp Immunol. 1980 Sep;41(3):487-96. Clin Exp Immunol. 1980. PMID: 7438562 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley